AGL 40.30 Increased By ▲ 0.29 (0.72%)
AIRLINK 127.05 Decreased By ▼ -0.94 (-0.73%)
BOP 6.62 Increased By ▲ 0.02 (0.3%)
CNERGY 4.49 Decreased By ▼ -0.11 (-2.39%)
DCL 8.63 Increased By ▲ 0.15 (1.77%)
DFML 41.89 Increased By ▲ 0.41 (0.99%)
DGKC 87.60 Increased By ▲ 1.02 (1.18%)
FCCL 32.78 Increased By ▲ 0.64 (1.99%)
FFBL 65.25 Decreased By ▼ -0.17 (-0.26%)
FFL 10.25 No Change ▼ 0.00 (0%)
HUBC 109.76 Decreased By ▼ -0.73 (-0.66%)
HUMNL 14.88 Increased By ▲ 0.13 (0.88%)
KEL 5.13 No Change ▼ 0.00 (0%)
KOSM 7.53 Increased By ▲ 0.41 (5.76%)
MLCF 41.70 Increased By ▲ 0.05 (0.12%)
NBP 59.51 Decreased By ▼ -0.58 (-0.97%)
OGDC 194.29 Decreased By ▼ -0.40 (-0.21%)
PAEL 28.26 Increased By ▲ 0.31 (1.11%)
PIBTL 7.82 Decreased By ▼ -0.18 (-2.25%)
PPL 152.45 Increased By ▲ 1.28 (0.85%)
PRL 26.55 Decreased By ▼ -0.33 (-1.23%)
PTC 16.12 Increased By ▲ 0.12 (0.75%)
SEARL 83.00 Increased By ▲ 4.80 (6.14%)
TELE 7.68 Increased By ▲ 0.29 (3.92%)
TOMCL 35.45 Decreased By ▼ -0.22 (-0.62%)
TPLP 8.18 Increased By ▲ 0.27 (3.41%)
TREET 16.19 Increased By ▲ 0.30 (1.89%)
TRG 53.00 Increased By ▲ 0.24 (0.45%)
UNITY 26.50 Decreased By ▼ -0.05 (-0.19%)
WTL 1.25 Decreased By ▼ -0.02 (-1.57%)
BR100 9,930 Increased By 9.7 (0.1%)
BR30 30,797 Increased By 45.1 (0.15%)
KSE100 93,636 Increased By 411.6 (0.44%)
KSE30 29,023 Increased By 138.5 (0.48%)
Top News

Thermo Fisher wins EU okay for Phadia takeover

BRUSSELS : US laboratory equipment maker Thermo Fisher Scientific Inc secured EU approval on Friday for its $3.5 billi
Published August 19, 2011

thermo-fisher-scientificBRUSSELS: US laboratory equipment maker Thermo Fisher Scientific Inc secured EU approval on Friday for its $3.5 billion purchase of Swedish diagnostics company Phadia to reinforce its portfolio of allergy and autoimmune disease tests.

Thermo, which announced the deal in May, has forecast a 26 to 30 cents per share boost to its 2012 earnings as a result of the acquisition.

"The Commission concluded that the transaction would not raise competition concerns, because the parties are not close competitors and the merged entity would be constrained by a sufficient number of third party competitors active in vitro autoimmune diseases diagnostics," the European Commission, the EU's competition watchdog, said in a statement.

Phadia, which is being sold by private equity firm Cinven, specialises in tests for airborne, food and pet allergies, and also tests for autoimmune diseases such as rheumatoid arthritis.

 

Copyright Reuters, 2011

 

Comments

Comments are closed.